Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Daniel WoolsonPresident | Icu MedicalICUI | Open-market sale | 05/22 | 05/22 | 2,123 sh | $132.21 | $280,681.83 | −8.6% |
Virginia Ruth SanzoneVP, General Counsel | Icu MedicalICUI | Open-market sale | 05/14 | 05/15 | 2,447 sh | $124.08 | $303,623.76 | −11.2% |
David C. GreenbergDirector | Icu MedicalICUI | Open-market sale | 05/12 | 05/13 | 2,424 sh | $122.91 | $297,933.84 | −23.3% |
Daniel WoolsonVP, GM-Infusion Capital | Icu MedicalICUI | Open-market sale | 25/11/25 | 25/11/25 | 2,897 sh | $152.35 | $441,357.95 | −20.4% |
Elisha W. FinneyDirector | Icu MedicalICUI | Open-market sale | 25/11/11 | 25/11/12 | 1,285 sh | $140.42 | $180,439.7 | −24.3% |
Virginia Ruth SanzoneVP, General Counsel | Icu MedicalICUI | Open-market sale | 25/11/11 | 25/11/12 | 930 sh | $142.35 | $132,385.5 | −14.6% |
Icu MedicalICUI | Open-market buy | 25/08/27 | 25/08/27 | 1,200 sh2 trades | $126.41avg. | $151,696.9 | +17.8% | |
Icu MedicalICUI | Open-market buy | 25/08/14 | 25/08/14 | 21,929 sh2 trades | $112.83avg. | $2,474,320.28 | +20.3% | |
Virginia Ruth SanzoneVP, General Counsel | Icu MedicalICUI | Open-market sale | 25/05/30 | 25/05/30 | 700 sh | $133.62 | $93,534 | −9.9% |
Icu MedicalICUI | Open-market sale | 25/05/27–25/05/28 | 25/05/28 | 9,930 sh2 trades | $129.74avg. | $1,288,367.5 | −62.0% | |
Icu MedicalICUI | Open-market sale | 25/05/22–25/05/23 | 25/05/23 | 9,918 sh2 trades | $130.02avg. | $1,289,488.77 | −66.9% | |
Icu MedicalICUI | Open-market sale | 25/05/20–25/05/21 | 25/05/21 | 9,788 sh2 trades | $135.05avg. | $1,321,823.81 | −72.5% | |
Elisha W. FinneyDirector | Icu MedicalICUI | Open-market sale | 25/05/19 | 25/05/20 | 600 sh | $138.92 | $83,352 | −15.6% |
Icu MedicalICUI | Open-market sale | 25/05/16–25/05/19 | 25/05/19 | 11,110 sh2 trades | $139.00avg. | $1,544,290 | −82.3% | |
Icu MedicalICUI | Open-market sale | 25/05/14–25/05/15 | 25/05/15 | 11,111 sh2 trades | $137.10avg. | $1,523,319.65 | −82.3% | |
Ben SousaChief Information Officer | Icu MedicalICUI | Open-market sale | 25/05/15 | 25/05/15 | 2,000 sh | $137.36 | $274,720 | −80.7% |
David C. GreenbergDirector | Icu MedicalICUI | Open-market sale | 25/05/13 | 25/05/13 | 1,942 sh | $143.66 | $278,987.72 | −22.3% |
Vivek JainChairman and CEO | Icu MedicalICUI | Open-market sale10b5-1 plan | 25/01/02 | 25/01/02 | 1,373 sh | $155.48 | $213,474.04 | −1.3% |
Daniel WoolsonVP, GM-Infusion Capital | Icu MedicalICUI | Open-market sale | 24/12/06 | 24/12/06 | 2,241 sh | $156.25 | $350,156.25 | −17.1% |
Icu MedicalICUI | Open-market sale10b5-1 plan | 24/12/02 | 24/12/02 | 12,000 sh3 trades | $162.91avg. | $1,954,952.76 | −10.3% |